- Home
- PMCB vs JCTCF Comparison
PMCB vs JCTCF Comparison
Compare PMCB & JCTCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- JCTCF
- Stock Information
- Founded
- PMCB 1996
- JCTCF 1953
- Country
- PMCB United States
- JCTCF United States
- Employees
- PMCB N/A
- JCTCF N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- JCTCF RETAIL: Building Materials
- Sector
- PMCB Health Care
- JCTCF Consumer Discretionary
- Exchange
- PMCB Nasdaq
- JCTCF Nasdaq
- Market Cap
- PMCB 15.8M
- JCTCF 14.3M
- IPO Year
- PMCB N/A
- JCTCF 1996
- Fundamental
- Price
- PMCB $1.77
- JCTCF $4.94
- Analyst Decision
- PMCB
- JCTCF
- Analyst Count
- PMCB 0
- JCTCF 0
- Target Price
- PMCB N/A
- JCTCF N/A
- AVG Volume (30 Days)
- PMCB 37.6K
- JCTCF 7.1K
- Earning Date
- PMCB 09-17-2024
- JCTCF 11-26-2024
- Dividend Yield
- PMCB N/A
- JCTCF N/A
- EPS Growth
- PMCB N/A
- JCTCF N/A
- EPS
- PMCB 0.54
- JCTCF 0.34
- Revenue
- PMCB N/A
- JCTCF $48,553,695.00
- Revenue This Year
- PMCB N/A
- JCTCF N/A
- Revenue Next Year
- PMCB N/A
- JCTCF N/A
- P/E Ratio
- PMCB $3.31
- JCTCF $14.53
- Revenue Growth
- PMCB N/A
- JCTCF N/A
- 52 Week Low
- PMCB $1.39
- JCTCF $3.86
- 52 Week High
- PMCB $2.58
- JCTCF $6.35
- Technical
- Relative Strength Index (RSI)
- PMCB 48.90
- JCTCF 62.59
- Support Level
- PMCB $1.72
- JCTCF $4.85
- Resistance Level
- PMCB $2.06
- JCTCF $4.99
- Average True Range (ATR)
- PMCB 0.28
- JCTCF 0.12
- MACD
- PMCB -0.00
- JCTCF 0.01
- Stochastic Oscillator
- PMCB 38.24
- JCTCF 86.36
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About JCTCF Jewett-Cameron Trading Company
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in United States and also has its presence in Canada, Latin America, Europe and Asia and other regions.